Market Research Logo

Hematology Drugs Market Global Outlook 2018 Including: Blood Products, Hematology Drugs, Anemia And Other Blood Disorder DrugsCovering: Novo Nordisk A/S, Biogen Inc., Pfizer Inc., Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited

Hematology Drugs Market Global Outlook 2018 Including: Blood Products, Hematology Drugs, Anemia And Other Blood Disorder DrugsCovering: Novo Nordisk A/S, Biogen Inc., Pfizer Inc., Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited

North America was the largest region in the hematology drugs market in 2017, accounting for around 40% market share. This can be attributed to established healthcare market coupled with nationwide health insurance coverage in countries such as the USA and Canada. Western Europe was the second largest region accounting for around 20% market share. Asia Pacific was the third largest region accounting for around 18% market share.

Hematology Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global hematology drugs sector.

Reasons to Purchase

  • Fully updated for 2018.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Hematology Drugs Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the hematology drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the hematology drugs market and suggests approaches.

Scope

Markets Covered: Blood Products, Anemia And Other Blood Disorder Drugs.

Companies Mentioned: Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company Limited, Biogen Inc., Pfizer Inc.

Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Hematology Drugs Market Characteristics
Hematology Drugs Market Historic Growth (2013-17)
Hematology Drugs Market Forecast Growth (2017-21)
Hematology Drugs Market Segmentation
Global Hematology Drugs Market, Split By Segments, 2017, $ Billion
Blood Products
Anemia And Other Blood Disorder Drugs
Global Hematology Drugs Market, Historic and Forecast, Split By Segments, 2013-2021
Hematology Drugs Market Geography Regional and Country Comparison
Global Hematology Drugs Market, Split By Regions, 2017
Global Hematology Drugs Market, Historic And Forecast Growth (2017-21) Rate, Split By Region, 2013-2021
Global Hematology Drugs Market, Split By Country, 2017
Global Hematology Drugs Market, Historic And Forecast Growth (2017-21) Rate, Split By Country, 2013-2021
Hematology Drugs Market Competitive Landscape
Novo Nordisk A/S
Shire Plc.
Bayer AG
Daiichi Sankyo Company, Limited
Biogen Inc.
Pfizer Inc.
Novo Nordisk
Shire Plc.
Bayer AG
Hematology Drugs Market Key Mergers And Acquisitions
Sumitomo Dainippon Pharma Co. Ltd. Acquired Tolero Pharmaceuticals
Novartis Acquired Selexys Pharmaceuticals Corporation And SelG1 Antibody
Miragen Therapeutics, Inc. Merged With Signal Genetics, Inc.
RXi Pharmaceuticals Acquired MirImmune Inc.
Sorrento Therapeutics, Inc., Merged With Yuhan Corporation
Hematology Drugs Market Trends And Strategies
Tranexamic Acid To Prevent Postpartum Hemorrhage
Increase In Product Approvals for Hemophilia
Gene Therapy For Treatment Of Sickle-Cell Disease
Genetically Engineered Drug For Von Willebrand Disease (VWD)
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company
28

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report